Tourmaline Bio Enters into Agreement to be Acquired by Novartis AG
Go back to Tourmaline Bio Enters into Agreement to be Acquired by Novartis AG| (NASDAQ: TRML) | Delayed: 47.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.98 | 52 Week High | $ | |||
| Open | $47.98 | 52 Week Low | $ | |||
| Day High | $47.98 | P/E | N/A | |||
| Day Low | $47.98 | EPS | $ | |||
| Volume | 25,664 | |||||

